Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending July 2011. The report details a specific corporate action regarding share repurchases executed on July 14, 2011, pursuant to shareholder authority granted at the Annual General Meeting on May 5, 2011.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on capital structure changes related to share buybacks.
- Shares Purchased: 1,900,000 Ordinary shares of 25 pence each.
- Price Range: Highest price paid was 1,350.5 pence per share; lowest price paid was 1,333.0 pence per share.
- Treasury Holdings (Settled): 478,934,284 shares (8.55% of total issued share capital).
- Treasury Holdings (Including Unsettled): 483,584,284 shares (9.44% of total voting rights).
- Shares in Issue (Excluding Treasury): 5,124,418,998 shares.
Material Changes
The primary material change reported is the reduction of outstanding shares through the purchase of 1,900,000 shares on July 14, 2011. These shares are intended to be held in Treasury. Consequently, the percentage of total voting rights held in Treasury increased to 9.44% when including unsettled purchases.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. The document is a factual notification of a completed transaction.
Investor Verification Checklist
- Verify the total number of shares held in Treasury (478,934,284 settled) against the company's latest capitalization table.
- Confirm the total issued share capital excluding treasury shares (5,124,418,998) for accurate voting rights calculations.
- Review the price paid per share (1,333.0 to 1,350.5 pence) to assess the cost of capital return relative to market prices on July 14, 2011.
- Note that the filing does not contain financial performance data; refer to the most recent Form 20-F or interim results for revenue and profit metrics.